FIELD: chemical-pharmaceutical industry.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, which are effective as a dopamine reuptake inhibitor. In formula (I), X independently represents halogen, C1-C12 alkyl, C1-C12 alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is equal to 1 or 2; R1 and R2 independently represent H- or C1-C12 alkyl; R3 is H-, C1-C12 alkyl or C6-C12 aryl-C1-C12 alkyl; R4 is H- or C6-C12 aryl, wherein at least one of R1, R2, R3 and R4 is not H-.
.
EFFECT: invention also relates to a pharmaceutical composition containing said compounds, and a method of treating a disease associated with dopamine reuptake.
30 cl, 31 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOCARBONYLCARBAMATE COMPOUNDS | 2015 |
|
RU2790360C2 |
| COMPOUND CONTAINING OXADIAZOLE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT | 2019 |
|
RU2789456C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2019 |
|
RU2817800C2 |
| PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREIN AND ITS APPLICATION | 2009 |
|
RU2514827C2 |
| DERIVATIVES OF 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ON AS AGONISTS OF β-ADRENERGIC RECEPTORS | 2006 |
|
RU2406723C9 |
| PIPERAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | 1996 |
|
RU2126001C1 |
| 2-AMINO-4-PHENYL-4-OXOBUTYRIC DERIVATIVES ACID AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2139850C1 |
| SUBSTITUTED AMIDE COMPOUNDS | 2010 |
|
RU2609021C2 |
| PIPERIDINE ALKYL CARBAMATE DERIVATIVES, PRODUCTION THEREOF AND USE THEREOF AS FAAH ENZYME INHIBITORS | 2005 |
|
RU2384569C2 |
| ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
